triamcinolone has been researched along with Carcinoma, Renal Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barwe, SP; Damoiseaux, R; Franco, OE; Grubbs, SS; Hayward, SW; Huynh, TP; Lee, SJ; McSpadden, R; Petrelli, NJ; Rajasekaran, AK | 1 |
1 other study(ies) available for triamcinolone and Carcinoma, Renal Cell
Article | Year |
---|---|
Glucocorticoids suppress renal cell carcinoma progression by enhancing Na,K-ATPase beta-1 subunit expression.
Topics: Animals; Carcinoma, Renal Cell; Cell Adhesion; Cell Line, Tumor; Dexamethasone; Disease Progression; Fluorometholone; Glucocorticoids; HeLa Cells; High-Throughput Screening Assays; Humans; Kidney Neoplasms; Male; Mice; Mice, Hairless; Mice, SCID; Neoplasm Invasiveness; Promoter Regions, Genetic; RNA, Messenger; RNA, Neoplasm; Sodium-Potassium-Exchanging ATPase; Triamcinolone; Up-Regulation; Xenograft Model Antitumor Assays | 2015 |